Immutep Limited (ASX:IMM)
Australia · Delayed Price · Currency is AUD 0.4350
-0.0100 (-2.25%)
At close: Jan 9, 2026
Immutep Market Cap
Immutep has a market cap or net worth of 641.07 million as of January 9, 2026. Its market cap has increased by 27.66% in one year.
Market Cap
641.07M
Enterprise Value
513.00M
Revenue
5.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.44
Market Cap Chart
Since August 29, 1996, Immutep's market cap has increased from 3.66M to 641.07M, an increase of 17,401.37%. That is a compound annual growth rate of 19.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 641.07M | 4.82% |
| Dec 31, 2025 | 611.59M | 15.11% |
| Dec 31, 2024 | 531.29M | 29.54% |
| Dec 29, 2023 | 410.15M | 69.62% |
| Dec 30, 2022 | 241.81M | -42.22% |
| Dec 31, 2021 | 418.52M | 55.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 81.96B |
| Pro Medicus | 22.46B |
| Cochlear | 17.17B |
| Sonic Healthcare | 10.94B |
| Ramsay Health Care | 8.03B |
| Ansell | 5.07B |
| Telix Pharmaceuticals | 3.73B |
| Mesoblast | 3.50B |